ProPhase Labs introduces new Cold-EEZE Oral Spray

ProPhase Labs (NASDAQ: PRPH), makers of Cold-EEZE, a leader in over-the-counter (OTC) homeopathic cold remedies, continues to pioneer the category as they launch their first-ever Cold-EEZE Oral Spray. The new Oral Spray is formulated with zinc gluconate, the same effective active ingredient found in the best-selling, clinically proven and #1 pharmacist recommended Cold-EEZE lozenges. 

The effective proprietary formula reduces the severity and duration of the common cold. Two sprays offer the same amount of cold remedy (active ingredient zinc gluconate) as one Cold-EEZE lozenge.  The recommended two sprays per usage offer 13.3 mg of zinc gluconate and the bottle contains at least 45 doses (90 sprays). The new Oral Spray is available in a convenient, easy to carry spray bottle and is available in cherry and mint flavors.

"Our Cold-EEZE Oral Spray is a new opportunity to provide relief to our consumers in a new delivery system," says Ted Karkus, Chairman and Chief Executive Officer of ProPhase Labs. "Our lozenges have always been a leader in the over-the-counter cough & cold category and we saw Cold-EEZE Oral Spray as the logical next step in offering our consumers variety and alternatives to the traditional lozenge to help them reduce the severity and duration of their colds."